Literature DB >> 14738459

High levels of type 2 cytokine-producing cells in chronic fatigue syndrome.

A Skowera1, A Cleare, D Blair, L Bevis, S C Wessely, M Peakman.   

Abstract

The aetiology of chronic fatigue syndrome (CFS) is not known. However, it has been suggested that CFS may be associated with underlying immune activation resulting in a Th2-type response. We measured intracellular production of interferon (IFN)-gamma and interleukin (IL)-2; type 1 cytokines), IL-4 (type 2) and IL-10 (regulatory) by both polyclonally stimulated and non-stimulated CD4 and CD8 lymphocytes from patients with CFS and control subjects by flow cytometry. After polyclonal activation we found evidence of a significant bias towards Th2- and Tc2-type immune responses in CFS compared to controls. In contrast, levels of IFN-gamma, IL-2 and IL-10-producing cells were similar in both study groups. Non-stimulated cultures revealed significantly higher levels of T cells producing IFN-gamma or IL-4 in CFS patients. Concluding, we show evidence for an effector memory cell bias towards type 2 responsiveness in patients with CFS, as well as ongoing type 0 immune activation in unstimulated cultures of peripheral blood cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14738459      PMCID: PMC1808936          DOI: 10.1111/j.1365-2249.2004.02354.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  66 in total

Review 1.  The Th1/Th2 paradigm.

Authors:  S Romagnani
Journal:  Immunol Today       Date:  1997-06

2.  Immune responses associated with chronic fatigue syndrome: a case-control study.

Authors:  A C Mawle; R Nisenbaum; J G Dobbins; H E Gary; J A Stewart; M Reyes; L Steele; D S Schmid; W C Reeves
Journal:  J Infect Dis       Date:  1997-01       Impact factor: 5.226

3.  Influence of immediate hypersensitivity skin reactions on delayed reactions in patients with chronic fatigue syndrome.

Authors:  P Steinberg; A Pheley; P K Peterson
Journal:  J Allergy Clin Immunol       Date:  1996-12       Impact factor: 10.793

4.  Gulf War syndrome: is it due to a systemic shift in cytokine balance towards a Th2 profile?

Authors:  G A Rook; A Zumla
Journal:  Lancet       Date:  1997-06-21       Impact factor: 79.321

Review 5.  Glucocorticoids and immune function: unknown dimensions and new frontiers.

Authors:  T Wilckens; R De Rijk
Journal:  Immunol Today       Date:  1997-09

6.  Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome.

Authors:  K Konstantinov; A von Mikecz; D Buchwald; J Jones; L Gerace; E M Tan
Journal:  J Clin Invest       Date:  1996-10-15       Impact factor: 14.808

Review 7.  Chronic fatigue syndrome. A practical guide to assessment and management.

Authors:  M Sharpe; T Chalder; I Palmer; S Wessely
Journal:  Gen Hosp Psychiatry       Date:  1997-05       Impact factor: 3.238

8.  A scaled version of the General Health Questionnaire.

Authors:  D P Goldberg; V F Hillier
Journal:  Psychol Med       Date:  1979-02       Impact factor: 7.723

9.  Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial.

Authors:  A Deale; T Chalder; I Marks; S Wessely
Journal:  Am J Psychiatry       Date:  1997-03       Impact factor: 18.112

10.  A whole-blood technique for testing production of human interferon by leukocytes.

Authors:  H Kirchner; C Kleinicke; W Digel
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

View more
  43 in total

1.  Chronic fatigue syndrome is associated with diminished intracellular perforin.

Authors:  K J Maher; N G Klimas; M A Fletcher
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

Review 2.  Chronic fatigue syndrome: the need for subtypes.

Authors:  Leonard A Jason; Karina Corradi; Susan Torres-Harding; Renee R Taylor; Caroline King
Journal:  Neuropsychol Rev       Date:  2005-03       Impact factor: 7.444

3.  Immunological dysfunction, vaccination and Gulf War illness.

Authors:  Mark Peakman; Ania Skowera; Matthew Hotopf
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-04-29       Impact factor: 6.237

4.  Cytokines across the night in chronic fatigue syndrome with and without fibromyalgia.

Authors:  Toru Nakamura; Stephan K Schwander; Robert Donnelly; Felix Ortega; Fumiharu Togo; Gordon Broderick; Yoshiharu Yamamoto; Neil S Cherniack; David Rapoport; Benjamin H Natelson
Journal:  Clin Vaccine Immunol       Date:  2010-02-24

5.  Reduced levels of oestrogen receptor beta mRNA in Swedish patients with chronic fatigue syndrome.

Authors:  Hanna Gräns; Maria Nilsson; Karin Dahlman-Wright; Birgitta Evengård
Journal:  J Clin Pathol       Date:  2006-05-26       Impact factor: 3.411

6.  A formal analysis of cytokine networks in chronic fatigue syndrome.

Authors:  Gordon Broderick; Jim Fuite; Andrea Kreitz; Suzanne D Vernon; Nancy Klimas; Mary Ann Fletcher
Journal:  Brain Behav Immun       Date:  2010-05-04       Impact factor: 7.217

7.  Chronic Fatigue Syndrome: The Current Status and Future Potentials of Emerging Biomarkers.

Authors:  David Benjamin Fischer; Arsani Hany William; Adam Campbell Strauss; Elizabeth R Unger; Leonard Jason; Gailen D Marshall; Jordan D Dimitrakoff
Journal:  Fatigue       Date:  2014-06-01

8.  Clinical impact of B-cell depletion with the anti-CD20 antibody rituximab in chronic fatigue syndrome: a preliminary case series.

Authors:  Øystein Fluge; Olav Mella
Journal:  BMC Neurol       Date:  2009-07-01       Impact factor: 2.474

9.  Naturally arising human CD4 T-cells that recognize islet autoantigens and secrete interleukin-10 regulate proinflammatory T-cell responses via linked suppression.

Authors:  Timothy I M Tree; Jennifer Lawson; Hannah Edwards; Ania Skowera; Sefina Arif; Bart O Roep; Mark Peakman
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

10.  Plasma cytokines in women with chronic fatigue syndrome.

Authors:  Mary Ann Fletcher; Xiao Rong Zeng; Zachary Barnes; Silvina Levis; Nancy G Klimas
Journal:  J Transl Med       Date:  2009-11-12       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.